Dublin, July 17, 2023 (GLOBE NEWSWIRE) -- The "Vascular Closure Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Vascular Closure Devices estimated at US$824.6 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2022-2030.
Passive Approximators, one of the segments analyzed in the report, is projected to record a 8% CAGR and reach US$996.3 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Active Approximators segment is readjusted to a revised 6.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $340.6 Million, While China is Forecast to Grow at 8.6% CAGR
The Vascular Closure Devices market in the U.S. is estimated at US$340.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$154 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 6.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$112.3 Million by the year 2030.
Select Competitors (Total 36 Featured) -
- Abbott Laboratories
- Advanced Vascular Dynamics
- Cardinal Health, Inc.
- Cardival Medical, Inc.
- Endocor GmbH
- Medtronic PLC
- Merit Medical Systems Inc.
- Morris Innovative Inc.
- Teleflex Incorporated
- Terumo Corporation
- Transluminal Technologies LLC
- Tricol Medical Inc.
- Vivasure Medical Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 477 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $824.6 Million |
| Forecasted Market Value (USD) by 2030 | $1400 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Vascular Closure Devices - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Vascular Closure Devices - A Prelude
- Benefits
- Active Approximators
- Passive Approximators
- External Hemostatic Devices
- Vascular Closure Devices to Witness Steady Growth Post COVID-19
- Interventional Cardiology to Dominate the Market
- Passive Approximators Lead the Market
- Femoral Access Type Leads the Market
- United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth
- Competition
- Growth Restraints
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Medical Device Companies Focus on Developing Advanced Biomechanical VCDs
- Increasing Demand for Large-bore Vascular Closure Devices
- Select Large Bore Closure Devices
- Cardiovascular Diseases: A Significant Contributor to Market Growth
- Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
- Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
- Aging Population Drives Demand for Vascular Closure Devices
- Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
- Life Expectancy for Select Countries in Number of Years: 2019
- Increasing Healthcare Expenditure to Foster Growth
- World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
- Recent Approvals and Launches
- Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device
- Vascade MVP Vascular Closure System Obtains Approval from FDA
- Large Bore PerQseal Closure Device Introduced in Europe
- Cordis Introduces Mynx Control Vascular Closure Device
- FDA Approves Teleflex's Vascular Closure Device
- Vasorum Set to Commercialize a New Vascular Closure Device across the US
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/suycfk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
